By comparison, loss of HYAL-2 results in significant macrothrombocytopenia and dramatic accumulation of HA in the BM and MKs which impacts pro-platelet formation and increased platelet activation in response to the GPCR-agonist ADP [8, 9]. This evidence concerns the gene HYAL2 and Macrothrombocytopenia.